News | May 08, 2014

Elekta Launches Global Center of Excellence Program to Advance Cancer Management Efforts

Kettering Medical Center is first designated Center of Excellence

May 8, 2014 — Elekta has established a Center of Excellence program that seeks the collaboration of its clinical customers in the development of high-quality research, education and outreach to advance the treatment of cancer and brain disorders. Long-time Elekta solutions user, Kettering Medical Center (Kettering, Ohio) has been named the program's first Center of Excellence. The program seeks to provide patients suffering from cancer and brain disorders with extraordinary treatment based on a foundation of collaboration and learning with prestigious institutions and a shared commitment to clinical excellence.

"With its vast array of Elekta cancer management solutions — and more than two decades of history and collaboration with the company — Kettering Medical Center exemplifies the vision of the Center of Excellence program through its activities in its community and region and through its reputation as a world-class provider of clinical services," says Jay Hoey, executive vice president, Elekta North America. "We are proud to designate Kettering as the first such center."

According to Douglas B. Einstein, M.D., Ph.D., medical director and chairman of radiation oncology, Kettering Health Network, Elekta, Kettering and its patients will benefit from the center's participation in the Center of Excellence program. "Together, we have created a center that provides academic-class care and treatments in a setting local to our patient population," he says. "We have every tool we need to treat the most complex cases and know that future evolution will only expand that array of equipment. Even cancer patients far from our hospital will benefit, as Elekta takes much of the experience gained at Kettering and applies it to assist other departments to deliver the same type of care."

Building on its experience in treatment planning, Kettering has become a MOSAIQ Oncology Information System beta site and a Monaco treatment planning system alpha site, both of which allow direct communication between Elekta product management and Kettering's radiation oncology staff.

"This collaboration allows both parties to push forward together," Einstein adds, "With Elekta receiving immediate feedback on any issues, while Kettering receives the latest software and has an impact on desired future developments."

In addition, many of Kettering's radiation oncologists and staff members give presentations at a variety of national meetings.

"We attempt to not only showcase the Elekta hardware and software, but also assist our peers at the same time," he says. "Together we show that any center with the desire to provide high quality treatment can enter into a partnership with Elekta and have the tools to do it."

Kettering's association with Elekta includes its acquisition of linear accelerators it acquired nearly 20 years ago, and — over the years — Elekta treatment planning systems, oncology information systems and brachytherapy systems. Kettering also currently operates Elekta's Leksell Gamma Knife Perfexion radiosurgery system and Elekta Synergy radiotherapy system. In 2013, the center became the first U.S. hospital to install and begin using Elekta's state-of-the-art Versa HD radiation therapy system.

For more information:

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init